These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Riluzole: a glimmer of hope in the treatment of motor neurone disease. Kiernan MC Med J Aust; 2005 Apr; 182(7):319-20. PubMed ID: 15804220 [TBL] [Abstract][Full Text] [Related]
24. Riluzole for motor neurone disease. More trials are needed. Sandercock J; Burls A; Hyde C; Fry-Smith A; Barton P; Bryan S; Stewart A BMJ; 2001 May; 322(7297):1305. PubMed ID: 11403060 [No Abstract] [Full Text] [Related]
25. Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Hawryluk GW; Rowland J; Kwon BK; Fehlings MG Neurosurg Focus; 2008; 25(5):E14. PubMed ID: 18980474 [TBL] [Abstract][Full Text] [Related]
26. A Direct Comparison of Three Clinically Relevant Treatments in a Rat Model of Cervical Spinal Cord Injury. Hosier H; Peterson D; Tsymbalyuk O; Keledjian K; Smith BR; Ivanova S; Gerzanich V; Popovich PG; Simard JM J Neurotrauma; 2015 Nov; 32(21):1633-44. PubMed ID: 26192071 [TBL] [Abstract][Full Text] [Related]
28. A word of caution in extrapolating the riluzole spinal cord injury protective effects obtained in a rabbit model under ketamine anesthesia. Miyamoto TA; Miyamoto KJ J Thorac Cardiovasc Surg; 1999 Dec; 118(6):1156-7. PubMed ID: 10596003 [No Abstract] [Full Text] [Related]
29. Riluzole for motor neurone disease. Large, more economical trial is needed. Wheatley K; Gray R BMJ; 2001 May; 322(7297):1305. PubMed ID: 11403061 [No Abstract] [Full Text] [Related]
30. Mediating the Secondary Effects of Spinal Cord Injury Through Optimization of Key Physiologic Parameters. Haller J; Bice M; Lawrence B J Am Acad Orthop Surg; 2016 Mar; 24(3):160-71. PubMed ID: 26855116 [TBL] [Abstract][Full Text] [Related]
33. Drug evaluation: ProCord - a potential cell-based therapy for spinal cord injury. Kigerl K; Popovich P IDrugs; 2006 May; 9(5):354-60. PubMed ID: 16676272 [TBL] [Abstract][Full Text] [Related]
34. Methylprednisolone and other confounders to spinal cord injury clinical trials. Sipski ML; Pearse DD Nat Clin Pract Neurol; 2006 Aug; 2(8):402-3. PubMed ID: 16932592 [No Abstract] [Full Text] [Related]
35. Update on traumatic acute spinal cord injury. Part 1. Galeiras Vázquez R; Ferreiro Velasco ME; Mourelo Fariña M; Montoto Marqués A; Salvador de la Barrera S Med Intensiva; 2017 May; 41(4):237-247. PubMed ID: 28161028 [TBL] [Abstract][Full Text] [Related]
36. Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages. Gensel JC; Donnelly DJ; Popovich PG Expert Opin Ther Targets; 2011 Apr; 15(4):505-18. PubMed ID: 21281256 [TBL] [Abstract][Full Text] [Related]
37. Riluzole: what it does to spinal and brainstem neurons and how it does it. Cifra A; Mazzone GL; Nistri A Neuroscientist; 2013 Apr; 19(2):137-44. PubMed ID: 22596264 [TBL] [Abstract][Full Text] [Related]